ETF Opportunities Trust Cultivar ETF (BATS: CVAR)

Dernières nouvelles pour ETF Opportunities Trust Cultivar ETF (BATS:CVAR)

Healthcare

Industrials

Basic Materials

Technology

Consumer Defensive

Financial Services

Consumer Cyclical

Real Estate

Utilities

Energy

Communication Services

To achieve its investment objective, the Fund invests primarily in equity securities traded on U.S. exchanges of any size that the Funds investment adviser, Cultivar Capital, Inc. (the Adviser), believes are under-valued, or under-appreciated, by other participants in the broader equity market. In selecting securities for the Fund, the Adviser screens on an ongoing basis the Funds investment universe seeking such securities using an initial valuation assessment that is primarily quantitative, based on cash flow. The Advisers discounted cash flow model uses several key inputs to assess each securitys estimated intrinsic value.

Healthcare Services Group Inc

Core Laboratories Inc

Proto Labs Inc

Southwest Airlines Co.

Newmont Corp.

Barrick Gold Corporation

Marketaxess Holdings Inc?.?

Northwest Natural Holding Co

Paycom Software Inc.

Cultivar ETF

ETF Opportunities Trust Cultivar ETF

"We entered 2025 with positive momentum. However, the broader macroeconomic environment has changed significantly in recent months. The uncertainty created by U.S. tariffs and trade policy has been disruptive to the global automotive industry, and its global supply chains, thus impacting our production ramp. In turn, this has made our quest to ramp our own production both more challenging and more risky. In light of this new environment, we made the prudent decision to make changes to our previous plans. Notably, the decision to implement a temporary pause to prior production plans while we monitor ongoing manufacturing and supply chain conditions. Commensurately, we have taken actions to significantly reduce operating expenses. In addition, in March 2025 we raised new equity capital to ensure we are well positioned especially given today's challenging market environment and in light of the growing demand for our SDV technology, as the early stages of production ramp are expensive and impose a financial burden. These were not easy decisions, but they reflect our commitment to ensure the Company's long-term viability and success.
&nbsp;
"The critical question for REE in recent years has been identifying the right path to bring our technology to the customers who need it most. We are seeing that answer through a path of deploying our technology through less capital-intensive approaches, including licensing and partnership models. We are actively advancing several commercial opportunities along these lines, and we remain optimistic in our ability to serve customers and pursue growth in this way, even in the face of broader industry and trade headwinds. To be clear, production remains a part of our long-term strategy; the pause is presently seen as temporary. Heightened uncertainty in the current environment has led us, for now, to de-emphasize a near-term large-scale production ramp. We believe that this pause allows us to preserve cash, giving flexibility to adapt as market conditions evolve."
&nbsp;
&nbsp;
As part of our ongoing financial review, due to the recent changes in the macroeconomic environment and tariff situation negatively affecting our ability to bring our P7 to the market as planned and affecting our ability to raise debt, which directly impact our revenue forecast, management has determined that there is a substantial doubt about our ability to continue as a going concern for the next twelve months. Our plans to alleviate this going concern includes temporarily pausing production and significantly reducing costs, adjusting headcount with a view to optimize the corporate structure to become more flexible in the face of industry uncertainty. We will announce details of this in the near future, but for now, investors should expect significant reduction in operational expenses alongside the production pause.&nbsp;

Earnings

News

General

REE Automotive Said It Has Temporarily Paused Prior Production Plans While Monitoring Ongoing Manufacturing And Supply Chain Conditions

WIIM

VEON

VEON shares are trading higher after the company reported better-than-expected Q1 EPS and sales.

DLocal shares are trading higher after the company reported better-than-expected Q1 EPS and sales.

BIRK

Birkenstock shares are trading higher after the company reported better-than-expected Q2 EPS and sales.

BABA

Alibaba shares are trading lower after the company reported Q4 sales below estimates.

NTES

NetEase shares are trading higher after the company reported better-than-expected Q1 EPS and sales.

UBS analyst Daniel Major downgrades Alcoa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) from Buy to Neutral and announces $31 price target.

Downgrades

Price Target

Analyst Ratings

UBS Downgrades Alcoa to Neutral, Announces $31 Price Target

Needham analyst Laura Martin maintains Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) with a Buy and raises the price target from $12 to $14.

NEXN

Needham Maintains Buy on Nexxen International, Raises Price Target to $14

Scotiabank analyst Greg McGinniss downgrades Americold Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COLD#NYSE">COLD</a>) from Sector Outperform to Sector Perform and announces $20 price target.

COLD

Scotiabank Downgrades Americold Realty Trust to Sector Perform, Announces $20 Price Target

Needham analyst Laura Martin reiterates Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) with a Buy and maintains $84 price target.

Reiteration

Needham Reiterates Buy on Trade Desk, Maintains $84 Price Target

UNH: -7% &#x7C; <a href="https://www.benzinga.com//node/45432651">UnitedHealth shares are trading lower amid reports indicating the company is under investigation by the US Department of Justice for possible Medicare fraud.</a>
&nbsp;
CRWV: -9% &#x7C; <a href="https://www.benzinga.com//node/45419772">CoreWeave Q1 GAAP EPS $(1.49), Sales $981.63M Beat $859.77M Estimate</a>
&nbsp;
WMT: 3% &#x7C; <a href="https://www.benzinga.com//node/45432616">Walmart shares are trading higher following Q1 financial results.</a>

Movers

Trading Ideas

CRWV

Market-Moving News for May 15th

BOOT

Boot Barn Holdings shares are trading higher after the company issued Q1 guidance with its midpoint above estimates and announced a $200 million share repurchase program.

DXC Technology shares are trading lower after the company reported Q4 financial results and issued Q1 guidance below estimates. Also, the company issued FY26 adjusted EPS guidance below estimates.

Scotiabank analyst Konark Gupta upgrades CAE (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CAE#TSX">CAE</a>) from Sector Perform to Sector Outperform and announces C$42 price target.

Upgrades

TSX:CAE

Scotiabank Upgrades CAE to Sector Outperform, Announces C$42 Price Target

Improved Financial Position
<ul>
<li>$6.5 million cash on hand as of March 31, 2025 – nearly doubling from $3.6 million at year-end</li>
<li>Recent $5.0 million private placement in February 2025 supported strategic runway along with potential to raise an additional $5.0 million dollars from the exercise of warrants with an exercise price of $3.32 per share of common stock</li>
<li>Reduced operating cash burn from $2.7M in Q1 2024 to $1.3M in Q1 2025 due to cost optimization</li>
</ul>

SINT

SINTX Technologies Shifts Focus To Medical Device Commercialization, Citing Stronger Balance Sheet And Strategic Clarity

Zenas BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBIO#NASDAQ">ZBIO</a>) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(1.05) by 23.81 percent. This is a 95.53 percent increase over losses of $(17.89) per share from the same period last year. The company reported quarterly sales of $10.00 million which beat the analyst consensus estimate of $1.67 million by 498.80 percent.

Earnings Beats

ZBIO

Zenas BioPharma Q1 EPS $(0.80) Beats $(1.05) Estimate, Sales $10.00M Beat $1.67M Estimate

IMAB

I-Mab Reported Q1 Net Loss Per ADS Of $(0.04), Cash Balance Of $168.6M

&nbsp;Two subtype specific cohorts with ~15 patients each added to the ongoing RESET-Myositis&#x2122;&nbsp;trial –
RMAT designation granted for rese-cel in myositis, which is a disabling, multi-system autoimmune disease affecting approximately 80,000 U.S. patients with no approved treatments other than monthly IVIg –
Multiple Phase 1/2 disease cohorts fully enrolled across the RESET&#x2122; clinical development program; 44 patients enrolled and 23 patients dosed as of May 9, 2025
SLE and LN registrational discussions with FDA anticipated in 3Q25; systemic sclerosis registrational discussions with FDA anticipated in 4Q25 –
New clinical data on rese-cel in myositis, SLE / LN and systemic sclerosis to be presented in three oral sessions at the EULAR 2025 Congress in June –

CABA

Cabaletta Bio Eyes 2027 BLA Submission For Rese-cel In Myositis After FDA Alignment On Registrational Cohorts

CSCO

AlibabaCisco Systems shares are trading higher after the company reported better-than-expected Q3 financial results, raised its FY25 guidance, and issued Q4 adjusted EPS guidance above estimates.

Major cryptocurrencies are trading lower in early Thursday hours despite ongoing institutional demand and <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45374267/inflation-eases-in-april-as-trumps-tariffs-dont-push-prices-higher">cooling inflation data.</a>
Sentiment has shifted sharply, with the Crypto Fear &amp; Greed Index entering the &#8216;Greed&#8217; zone, raising questions whether this pullback signals a phase of profit-taking and consolidation following the robust rally over the past few weeks.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$101,782.26</td>
<td>-1.9%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,537.22</td>
<td>-2.3%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$169.23</td>
<td>-5.7%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.45</td>
<td>-5.6%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.2232</td>
<td>-5.2%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001484</td>
<td>-7.1%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows Bitcoin and Ethereum large transaction volume dropped 5.1% and 0.2%, respectively, in a single day. While ETH shows a 240% rise in exchange netflows, Bitcoin's daily active addresses are down 1.9%.</li>
<li>Coinglass data shows 157,967 traders were liquidated in the past 24 hours for $346.93 million.</li>
<li>SoSoValue data shows that spot Bitcoin ETFs saw a net inflow of $319.6 million, while spot Ethereum ETFs saw a $63.5 million net inflow.</li>
<li>Santiment data <a href="https://x.com/santimentfeed/status/1922717938986922260">shows</a> the daily average of new wallet creations over the past month: Bitcoin leads with 309,000 new wallets per day, followed by Ethereum at 112,000, USDT at 36,400, and XRP with 3,500 daily.</li>
<li>According to CoinMarketCap, the Crypto Fear &amp; Greed Index has surged to 71, entering the Greed zone, up sharply from the neutral range (40–60) recorded in early May.</li>
</ul>
Trader Notes: Bitcoin is finding key support around $101,600, according to crypto chart analyst Ali Martinez.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Key support for <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> right now is at $101,600! <a href="https://t.co/4cOpEJAPuA">pic.twitter.com/4cOpEJAPuA</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1922913059825189315?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, trader Adam <a href="https://x.com/abetrade/status/1922950159354175810">observed</a> that Bitcoin appears exhausted after its climb to $105,000, with open interest returning to levels seen near previous all-time highs. 
He notes that spot markets are encountering increased selling pressure, and while the move from $80,000 suggests a solid base, this may not be an optimal time to open new long positions.
Martinez also <a href="https://x.com/ali_charts/status/1922941887326917041">highlighted</a> that Ethereum has closed above its 200-period simple moving average on the 3-day chart, currently around $2,700. 
Historically, such a close has marked the beginning of major bull rallies for ETH.
For Solana, analyst Crypto Zeinab <a href="https://x.com/CryptoZeinab/status/1922949454367265013">notes</a> that the coin is currently retesting the $180 breakout level. 
A successful bullish retest could open the path toward $200. 
Supporting this outlook, Glassnode<a href="https://x.com/glassnode/status/1922931170691412455"> data</a> shows positive 30-day capital inflows of around 4–5% for SOL after months of outflows, signalling renewed investor interest, now on par with XRP.
Bluntz Capital pointed out that Dogecoin is forming a textbook inverse head and shoulders (IHS) pattern. The breakout occurred with strong volume, and the current pullback is seen as a healthy consolidation, potentially setting up for further upside.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">quite liking <a href="https://twitter.com/search?q=%24doge&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$doge</a> here aswell for continued upside, textbook IHS with volume in the breakout with a nice pullback here <a href="https://t.co/7iYf5fk9Vo">pic.twitter.com/7iYf5fk9Vo</a>
&mdash; Bluntz (@Bluntz_Capital) <a href="https://twitter.com/Bluntz_Capital/status/1922845477512372626?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45417306/michael-saylors-bitcoin-strategy-infinite-money-glitch-or-a-reflexive-leverage-bet">Michael Saylor&#8217;s Bitcoin Strategy—&#8217;Infinite Money Glitch&#8217; Or A Reflexive Leverage Bet?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$SHIB

$SOL

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Down As Sentiment Turns To Greed

Comments

ETF Opportunities Trust Cultivar ETF

Actualités

Dernières nouvelles pour ETF Opportunities Trust Cultivar ETF (BATS:CVAR)

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL